Stewart, Adam G.
Edwards, Felicity
Harris, Patrick N. A.
Paterson, David L.
Laupland, Kevin B.
Article History
Received: 16 November 2023
Accepted: 5 December 2024
First Online: 18 December 2024
Declarations
:
: The Human Research Ethics Committee (HREC) at Royal Brisbane and Women’s Hospital approved this study and granted a waiver of individual consent (LNR/2020/QRBW/62494).
: Not applicable.
: Not applicable.
: DLP has received research grants from Merck, Pfizer, bioMerieux and Shionogi outside of the submitted work. He has also received personal fees from AMR Action Fund, Merck, Pfizer, Shionogi, Spero, Lysovant, The Medicines Company, Entasis, VenatoRx, QPex, bioMerieux and Accelerate and is conducting a study on E. coli vaccination sponsored by Janssen. PNAH has received research grants from Merck, Sharpe and Dohme (MSD), Sandoz and Shionogi Ltd, outside of the submitted work, and has served on advisory boards for OpGen, Merck and Sandoz and received speakers fees from Pfizer, OpGen and Sandoz paid to the University of Queensland. All other authors: none to declare.